Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Expert Review of Cardiovascular Therapy
|
September 1, 2011
Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease
Roberto Ferrari, Claudio Ceconi
European Journal of Preventive Cardiology
|
May 14, 2020
Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19
Edoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology
|
February 13, 2021
The strange case of hydroxychloroquine and COVID-19
Edoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology
|
March 20, 2020
Diabetes mellitus and chronic kidney disease: A neglected and dangerous liaison
Edoardo Sciatti, Claudio Ceconi
American Journal of Respiratory and Critical Care Medicine
|
October 25, 2006
One heart, two lungs together forever
Claudio Ceconi, Roberto Ferrari
European Journal of Preventive Cardiology
|
August 13, 2019
Levels of evidence in the European Society of Cardiology Guidelines: Gaps in knowledge?
Massimo F Piepoli, Claudio Ceconi
Pharmacological Research
|
April 29, 2006
Anti-ischaemic effect of ivabradine
Roberto Ferrari, Anna Cargnoni, Claudio Ceconi
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines
Giuseppe M C Rosano, Claudio Ceconi
European Journal of Preventive Cardiology
|
June 24, 2017
The dangerous liaison: Coronary and kidney disease
Claudio Ceconi, Ester M G Costantino
Cardiovascular Drugs and Therapy
|
June 26, 2010
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium
Roberto Ferrari, Gabriele Guardigli, Claudio Ceconi
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Expert Review of Cardiovascular Therapy
|
September 1, 2011
Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease
Roberto Ferrari, Claudio Ceconi
European Journal of Preventive Cardiology
|
May 14, 2020
Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19
Edoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology
|
February 13, 2021
The strange case of hydroxychloroquine and COVID-19
Edoardo Sciatti, Claudio Ceconi
European Journal of Preventive Cardiology
|
March 20, 2020
Diabetes mellitus and chronic kidney disease: A neglected and dangerous liaison
Edoardo Sciatti, Claudio Ceconi
American Journal of Respiratory and Critical Care Medicine
|
October 25, 2006
One heart, two lungs together forever
Claudio Ceconi, Roberto Ferrari
European Journal of Preventive Cardiology
|
August 13, 2019
Levels of evidence in the European Society of Cardiology Guidelines: Gaps in knowledge?
Massimo F Piepoli, Claudio Ceconi
Pharmacological Research
|
April 29, 2006
Anti-ischaemic effect of ivabradine
Roberto Ferrari, Anna Cargnoni, Claudio Ceconi
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines
Giuseppe M C Rosano, Claudio Ceconi
European Journal of Preventive Cardiology
|
June 24, 2017
The dangerous liaison: Coronary and kidney disease
Claudio Ceconi, Ester M G Costantino
Cardiovascular Drugs and Therapy
|
June 26, 2010
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium
Roberto Ferrari, Gabriele Guardigli, Claudio Ceconi
Page
of 8